Melox (Meloxicam)

Meloxicam inhibits cyclooxygenase enzymes, especially COX‑2, which decreases the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. By lowering prostaglandin levels, meloxicam helps control the inflammatory response in joints and tissues.

The specific dose of Melox is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Dosage adjustments may be needed for renal or hepatic impairment, and the prescriber will provide individualized instructions.

The safety of meloxicam in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To request Melox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Melox (meloxicam) offers preferential COX‑2 inhibition, which may provide effective anti‑inflammatory relief with a potentially lower risk of gastrointestinal side effects compared with non‑selective NSAIDs such as ibuprofen or naproxen. However, individual response and safety profiles vary, so clinicians choose therapy based on patient‑specific factors.

Melox should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Melox is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water; do not crush or chew unless specifically instructed.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, and severe liver injury. Patients should be monitored for signs of these conditions, and therapy should be discontinued if serious adverse reactions occur.

Melox is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, and patients with severe renal or hepatic impairment unless specifically advised by a physician.